Kory Wentworth
Director of Finance/CFO chez ENTRADA THERAPEUTICS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Kory James Wentworth is currently the Chief Financial Officer & Treasurer at Entrada Therapeutics, Inc. Prior to this, he worked as the Executive Director & Corporate Controller at Alexion Pharmaceuticals, Inc. from 2008 to 2017 and as the Treasurer & Vice President-Finance at bluebird bio, Inc. from 2017 to 2020.
He completed his undergraduate degree at Susquehanna University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0,25% | 15/03/2024 | 83 170 ( 0,25% ) | 1 M $ | 31/03/2024 |
Postes actifs de Kory Wentworth
| Sociétés | Poste | Début |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director of Finance/CFO | 01/11/2020 |
Anciens postes connus de Kory Wentworth
| Sociétés | Poste | Fin |
|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 08/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Director/Board Member | 01/12/2017 |
Formation de Kory Wentworth
| Susquehanna University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
